Trilogy Capital’s Agilent Technologies A Stock Holding History

Trilogy Capital’s Portfolio A Stock Details A Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-167	Closed	-$12K	–	132
2018 Q3	$12K	Hold	167	–	–	﹤0.01%	310
2018 Q2	$10K	Buy	+167	New	+$10.9K	﹤0.01%	296

Other funds holding A

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Trilogy Capital's A Position: Q4 2018 in Review

Trilogy Capital sold out of Agilent Technologies (A) in Q4 2018, closing a stake of 167 shares — an estimated $12K sold.

Trilogy Capital first reported a position in A in Q2 2018 and held it in 2 quarters. The position peaked at $12K in Q3 2018. 694 funds tracked by Wall St. Rank hold A as of Q4 2018.

Trilogy Capital reported no remaining Agilent Technologies position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 167 Agilent Technologies shares in Q4 2018, an estimated $12K.
Trilogy Capital first reported a position in Agilent Technologies in Q2 2018 and held it in 2 quarters.
Trilogy Capital's Agilent Technologies position peaked at $12K in Q3 2018.
694 funds tracked by Wall St. Rank held Agilent Technologies as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.